Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group

Serum albumin a well‐known risk factor predicting outcome in many solid tumors. We explore the role of low serum albumin (≤3.5 g/dL) as an independent risk factor in elderly patients with aggressive B‐cell lymphoma. Outcome of 429 patients treated with R‐CHOP‐14 in the RICOVER‐60 trial and available...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohloch, Karin, Ziepert, Marita, Truemper, Lorenz, Buske, Christian, Held, Gerhard, Poeschel, Viola, Chapuy, Bjoern, Altmann, Bettina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175786/
https://www.ncbi.nlm.nih.gov/pubmed/35847697
http://dx.doi.org/10.1002/jha2.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175786/
https://www.ncbi.nlm.nih.gov/pubmed/35847697
http://dx.doi.org/10.1002/jha2.61

Ejemplares similares